In 2024, Lupin's return on assets (ROA) was 0.08, a -213.93% increase from the -0.07 ROA in the previous year.

Lupin Aktienanalyse

What does Lupin do?

Lupin Limited is an Indian pharmaceutical company specializing in generics and novel therapies. It was founded in 1968 by Dr. Desh Bandhu Gupta and has experienced rapid growth, becoming one of the leading companies in the global pharmaceutical market. The company's business model involves manufacturing and marketing generics and novel therapies for the treatment of various diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases. Lupin operates worldwide with a wide range of partners to distribute its products in over 100 countries. The company is involved in various divisions including generics, novel therapies, biosimilars, and inhalation products. Lupin's generics division encompasses a wide range of products such as antibiotics, antidepressants, antihypertensives, and many other categories. Its novel therapies include innovative products for the treatment of diabetes, cancer, multiple sclerosis, and other chronic diseases. Lupin is also involved in the development of biosimilars, which are imitation biopharmaceuticals manufactured using living organisms. Lastly, the company offers inhalation products for the treatment of respiratory diseases such as asthma and COPD. Lupin has built an impressive product pipeline over the years, having submitted over 174 ANDA applications (for the approval of new generics) to the US FDA and introduced more than 80 new products in the Indian market. It has also established an innovative research and development center that focuses on the discovery of new molecules and the development of new therapeutic approaches. Another important feature of Lupin is its commitment to quality and sustainability. The company has received numerous awards for its product quality and environmental initiatives. In 2019, Lupin received the Sustainable Business Award from CNBC TV18. Overall, Lupin Limited is a successful and fast-growing company specializing in generics and novel therapies. It has a wide range of products and an impressive pipeline, and operates globally. Due to its commitment to quality and sustainability, Lupin Limited has also built a strong reputation among its customers and partners. Lupin ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Lupin's Return on Assets (ROA)

Lupin's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Lupin's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Lupin's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Lupin’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Lupin stock

What is the Return on Assets (ROA) of Lupin this year?

The Return on Assets (ROA) of Lupin is 0.08 undefined this year.

What was the ROA of Lupin compared to the previous year?

The ROA of Lupin has increased by -213.93% compared to the previous year.

What consequences do high ROA have for investors of Lupin?

A high ROA is advantageous for investors of Lupin, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Lupin?

A low ROA can be unfavorable for investors of Lupin as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Lupin affect the company?

An increase in ROA of Lupin can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Lupin impact the company?

A reduction in the ROA of Lupin can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Lupin?

Some factors that can influence the ROA of Lupin include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Lupin important for investors?

The ROA of Lupin is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Lupin take to improve ROA?

To improve ROA, Lupin can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Lupin pay?

Over the past 12 months, Lupin paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lupin is expected to pay a dividend of 7.37 INR.

What is the dividend yield of Lupin?

The current dividend yield of Lupin is .

When does Lupin pay dividends?

Lupin pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Lupin?

Lupin paid dividends every year for the past 23 years.

What is the dividend of Lupin?

For the upcoming 12 months, dividends amounting to 7.37 INR are expected. This corresponds to a dividend yield of 0.35 %.

In which sector is Lupin located?

Lupin is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lupin kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lupin from 9/1/2024 amounting to 8 INR, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Lupin pay the last dividend?

The last dividend was paid out on 9/1/2024.

What was the dividend of Lupin in the year 2023?

In the year 2023, Lupin distributed 4 INR as dividends.

In which currency does Lupin pay out the dividend?

The dividends of Lupin are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lupin

Our stock analysis for Lupin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lupin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.